S-1/A: Mitesco, Inc. Files Amendment #2 to Form S-1/A for Potential Resale of 15.3 Million Shares

Mitesco, Inc. is filing an amendment to its registration statement for the potential resale of up to 15,278,771 shares of common stock by selling stockholders.

Summary

• Mitesco, Inc. has filed Amendment #2 to its Form S-1/A registration statement with the SEC.
• The filing pertains to the potential resale of up to 15,278,771 shares of the company's common stock.
• These shares are to be offered by the Selling Stockholders identified in the prospectus.
• The shares consist of (i) 2,628,179 shares issued in connection with the restructuring of approximately $12.5 million worth of financial obligations, (ii) 9,978,907 shares issuable upon the mandatory redemption of Series A Amortizing Convertible Preferred Stock, and (iii) 2,671,685 shares previously issued in unregistered offerings.
• The company is fulfilling its contractual obligations to register the resale of these shares.
• Mitesco will not receive any proceeds from the sale of these shares.
• The Selling Stockholders may offer or sell the shares from time to time through public or private transactions at a fixed price of $4.00 per share so long as the Common Stock is trading on the OTC Pink Market.
• If and when the shares of Common Stock are listed on a national securities exchange, or quoted on the OTC Bulletin Board, OTCQX, or OTCQB, the Selling Stockholders may offer or sell the shares at prevailing market prices or at privately negotiated prices.
• As of May 6, 2025, the last reported bid price of Mitesco's Common Stock on the Pink Market was $0.32.
• The company is a smaller reporting company and has elected to comply with certain reduced public company reporting requirements.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it highlights the company's efforts to restructure its debt and explore new business ventures, it also emphasizes the significant risks and uncertainties, including the company's going concern status and the potential for dilution.

Positives

• The registration statement fulfills Mitesco's contractual obligations to register the resale of common stock.
• The debt restructuring aims to reduce the company's financial obligations.
• The company has an Advisory Board which includes participants with significant experience and who are compensated through the issuance of restricted stock so as to align their interests with those of the shareholders.

Negatives

• The company will not receive any proceeds from the resale of common stock by the Selling Stockholders.
• The company's common stock is currently traded on the Pink Market of the OTC, with a last reported bid price of $0.32 on May 6, 2025.
• Investing in the common stock is highly speculative and involves a high degree of risk.

Risks

• The company is in the initial stages of its present business plan and has a limited historical performance.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company may need to raise additional capital, which may not be available on acceptable terms or at all.
• Redemption of all shares of Series A Preferred Stock into Common Stock may lead to severe dilution of existing shares.
• Resales of the company's Common Stock in the public market by stockholders as a result of this offering may cause the market price of the Common Stock to fall.
• The company faces the risk of unauthorized access to or breaches of its information systems.

Future Outlook

The company's future revenues and profitability depend upon its ability to successfully implement a growth strategy. The company intends to redeem the Series A Preferred shares using common stock for the foreseeable future.

Industry Context

The data services industry is a highly competitive and established market with an abundance of domestic and international firms offering services similar to Mitesco's.

Comparison to Industry Standards

• Mitesco faces competition from traditional global IT systems integrators, such as Accenture, Atos, Capgemini, Cognizant, Deloitte, DXC Technology and IBM.
• The company also competes with cloud service providers and digital systems integrators, regional and national managed services providers, and colocation providers, such as Equinix, CyrusOne and QTS.

Legal Proceedings

• The Company has a number of legal situations involved with the winding down of its clinic business activities, including claims regarding certain construction contracts and cancellation of leases.

Related Party Transactions

• The company entered into a debt-for-equity exchange agreement with Gardner Builders Holdings, LLC.
• On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC.
• The company acquired the source code and business activities of AgingTopic, LLC, an entity controlled by Ms. Amy Lance, the wife of Mack Leath.

Stakeholder Impact

• Redemption of all shares of Series A Preferred Stock into Common Stock may lead to severe dilution of existing shares.
• Resales of the company's Common Stock in the public market by stockholders as a result of this offering may cause the market price of the Common Stock to fall.

Next Steps

• The company intends to redeem the Series A Preferred shares using common stock for the foreseeable future.
• The company is undertaking to change its trading platform from the OTC Pink Market on to the OTCQB Venture Market.

Key Dates

Keywords

common stock, registration statement, resale, Series A Preferred Stock, debt restructuring, Mitesco, selling stockholders, OTC Pink Market, securities, shares